Edition:
United States

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

1.87USD
23 Feb 2018
Change (% chg)

$0.03 (+1.63%)
Prev Close
$1.84
Open
$1.86
Day's High
$1.90
Day's Low
$1.80
Volume
143,853
Avg. Vol
538,595
52-wk High
$2.87
52-wk Low
$1.32

Select another date:

Fri, Feb 16 2018

BRIEF-Great Point Partners Opposes Biocryst Pharma Proposed Merger With Idera Pharma

* GREAT POINT PARTNERS LLC OPPOSES THE BIOCRYST PHARMACEUTICAL PROPOSED MERGER WITH IDERA PHARMACEUTICALS, INC.

BRIEF-Biocryst Pharma And Idera Pharma Sign Merger Agreement To Form New Company

* BIOCRYST PHARMACEUTICALS AND IDERA PHARMACEUTICALS ANNOUNCE MERGER TO COMBINE CAPABILITIES TO SERVE MORE PATIENTS WITH RARE DISEASES

BRIEF-Idera Pharmaceuticals Provides 2018 Update And Outlook

* IDERA PHARMACEUTICALS - ANTICIPATES CURRENT CASH POSITION CAPABLE OF FUNDING OPERATIONS INTO Q2 2019 Source text for Eikon: Further company coverage:

BRIEF-U.S. FDA Grants Fast Track Designation For Idera Pharmaceuticals’ IMO-2125 In Combination With Ipilimumab

* U.S. FDA GRANTS FAST TRACK DESIGNATION FOR IDERA PHARMACEUTICALS’ IMO-2125 IN COMBINATION WITH IPILIMUMAB FOR TREATMENT OF PD-1 REFRACTORY METASTATIC MELANOMA Source text for Eikon: Further company coverage:

BRIEF-Idera Pharmaceuticals presents positive translational and clinical data update from ongoing IMO-2125 development program

* Idera Pharmaceuticals Inc presents positive translational and clinical data update from ongoing IMO-2125 development program at the 2017 society for immunotherapy of cancer annual meeting (SITC)

BRIEF-Idera Pharmaceuticals reports Q3 loss per share $0.10

* Idera Pharmaceuticals reports third quarter 2017 financial results and provides corporate update

BRIEF-Idera Pharma announces pricing of public offering of common stock

* Idera Pharmaceuticals announces pricing of public offering of common stock

BRIEF-Idera Pharmaceuticals provides corporate governance update

* Idera Pharmaceuticals provides corporate governance update Source text for Eikon: Further company coverage:

BRIEF-Idera Pharmaceuticals announces proposed public offering of common stock

* Idera Pharmaceuticals announces proposed public offering of common stock

Select another date: